MedicineCOVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer TreatmentsParticipation rates were already low, but the pandemic threatens to drive them even lowerJuly 9, 2020 — Pat Basu and Maurie Markman | Opinion